The incredible potential of gene therapies like CAR-T and CRISPR to cure genetic diseases and cancers marks a new era in medicine, yet most patients still lack access to these life-saving treatments. For many, the promise of gene therapy remains out of reach due to barriers like high costs, limited treatment availability, and healthcare inequities. In the November 2024 Bridging the Gap webinar, guest speakers Jimi Olaghere, a sickle cell survivor and advocate, and Dr. Fyodor Urnov, Professor of Molecular Therapeutics at UC Berkeley, tackled this pressing issue. Their conversation explored the revolutionary impact of gene-editing therapies and highlighted the obstacles—financial, logistical, and systemic—that prevent equitable access. Read more in our latest newsletter.
